Associations between circulating 1,25(OH)2D concentration and odds of metachronous colorectal adenoma

Elizabeth A. Hibler, Christine L. Sardo Molmenti, Peter Lance, Peter Jurutka, Elizabeth T. Jacobs

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Cellular-level studies demonstrate that the availability of the secosteroid hormone 1α,25-dihydroxyvitamin D [1,25(OH)2D] to colon cells promotes anti-carcinogenic activities. Although epidemiological data are relatively sparse, suggestive inverse trends have been reported between circulating 1,25(OH)2D concentration and colorectal neoplasia. We therefore sought to evaluate the relationship between circulating 1,25(OH) 2D concentrations and odds for metachronous colorectal adenomas among 1,151 participants from a randomized trial of ursodeoxycholic acid for colorectal adenoma prevention. No relationship between 1,25(OH)2D and overall odds for metachronous lesions was observed, with ORs (95 % CIs) of 0.80 (0.60-1.07) and 0.81 (0.60-1.10) for participants in the second and third tertiles, respectively, compared with those in the lowest (p-trend = 0.17). However, a statistically significant inverse association was observed between circulating 1,25(OH)2D concentration and odds of proximal metachronous adenoma, with an OR (95 % CI) of 0.71 (0.52-0.98) for individuals in the highest tertile of 1,25(OH)2D compared with those in the lowest (p-trend = 0.04). While there was no relationship overall between 1,25(OH)2D and metachronous distal lesions, there was a significantly reduced odds for women, but not men, in the highest 1,25(OH)2D tertile compared with the lowest (OR 0.53; 95 % CI 0.27-1.03; p-trend = 0.05; p-interaction = 0.08). The observed differences in associations with proximal and distal adenomas could indicate that delivery and activity of vitamin D metabolites in different anatomic sites in the colorectum varies, particularly by gender. These results identify novel associations between 1,25(OH) 2D and metachronous proximal and distal colorectal adenoma, and suggest that future studies are needed to ascertain potential mechanistic differences in 1,25(OH)2D action in the colorectum.

Original languageEnglish (US)
Pages (from-to)809-817
Number of pages9
JournalCancer Causes and Control
Volume25
Issue number7
DOIs
StatePublished - 2014

Fingerprint

Adenoma
Secosteroids
Ursodeoxycholic Acid
Vitamin D
Colon
Hormones
Neoplasms

Keywords

  • Colon cancer
  • Colorectal adenoma
  • Vitamin D

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Medicine(all)

Cite this

Associations between circulating 1,25(OH)2D concentration and odds of metachronous colorectal adenoma. / Hibler, Elizabeth A.; Sardo Molmenti, Christine L.; Lance, Peter; Jurutka, Peter; Jacobs, Elizabeth T.

In: Cancer Causes and Control, Vol. 25, No. 7, 2014, p. 809-817.

Research output: Contribution to journalArticle

Hibler, Elizabeth A. ; Sardo Molmenti, Christine L. ; Lance, Peter ; Jurutka, Peter ; Jacobs, Elizabeth T. / Associations between circulating 1,25(OH)2D concentration and odds of metachronous colorectal adenoma. In: Cancer Causes and Control. 2014 ; Vol. 25, No. 7. pp. 809-817.
@article{b5fe4555fa5e4e15896679551f757dd1,
title = "Associations between circulating 1,25(OH)2D concentration and odds of metachronous colorectal adenoma",
abstract = "Cellular-level studies demonstrate that the availability of the secosteroid hormone 1α,25-dihydroxyvitamin D [1,25(OH)2D] to colon cells promotes anti-carcinogenic activities. Although epidemiological data are relatively sparse, suggestive inverse trends have been reported between circulating 1,25(OH)2D concentration and colorectal neoplasia. We therefore sought to evaluate the relationship between circulating 1,25(OH) 2D concentrations and odds for metachronous colorectal adenomas among 1,151 participants from a randomized trial of ursodeoxycholic acid for colorectal adenoma prevention. No relationship between 1,25(OH)2D and overall odds for metachronous lesions was observed, with ORs (95 {\%} CIs) of 0.80 (0.60-1.07) and 0.81 (0.60-1.10) for participants in the second and third tertiles, respectively, compared with those in the lowest (p-trend = 0.17). However, a statistically significant inverse association was observed between circulating 1,25(OH)2D concentration and odds of proximal metachronous adenoma, with an OR (95 {\%} CI) of 0.71 (0.52-0.98) for individuals in the highest tertile of 1,25(OH)2D compared with those in the lowest (p-trend = 0.04). While there was no relationship overall between 1,25(OH)2D and metachronous distal lesions, there was a significantly reduced odds for women, but not men, in the highest 1,25(OH)2D tertile compared with the lowest (OR 0.53; 95 {\%} CI 0.27-1.03; p-trend = 0.05; p-interaction = 0.08). The observed differences in associations with proximal and distal adenomas could indicate that delivery and activity of vitamin D metabolites in different anatomic sites in the colorectum varies, particularly by gender. These results identify novel associations between 1,25(OH) 2D and metachronous proximal and distal colorectal adenoma, and suggest that future studies are needed to ascertain potential mechanistic differences in 1,25(OH)2D action in the colorectum.",
keywords = "Colon cancer, Colorectal adenoma, Vitamin D",
author = "Hibler, {Elizabeth A.} and {Sardo Molmenti}, {Christine L.} and Peter Lance and Peter Jurutka and Jacobs, {Elizabeth T.}",
year = "2014",
doi = "10.1007/s10552-014-0382-6",
language = "English (US)",
volume = "25",
pages = "809--817",
journal = "Cancer Causes and Control",
issn = "0957-5243",
publisher = "Springer Netherlands",
number = "7",

}

TY - JOUR

T1 - Associations between circulating 1,25(OH)2D concentration and odds of metachronous colorectal adenoma

AU - Hibler, Elizabeth A.

AU - Sardo Molmenti, Christine L.

AU - Lance, Peter

AU - Jurutka, Peter

AU - Jacobs, Elizabeth T.

PY - 2014

Y1 - 2014

N2 - Cellular-level studies demonstrate that the availability of the secosteroid hormone 1α,25-dihydroxyvitamin D [1,25(OH)2D] to colon cells promotes anti-carcinogenic activities. Although epidemiological data are relatively sparse, suggestive inverse trends have been reported between circulating 1,25(OH)2D concentration and colorectal neoplasia. We therefore sought to evaluate the relationship between circulating 1,25(OH) 2D concentrations and odds for metachronous colorectal adenomas among 1,151 participants from a randomized trial of ursodeoxycholic acid for colorectal adenoma prevention. No relationship between 1,25(OH)2D and overall odds for metachronous lesions was observed, with ORs (95 % CIs) of 0.80 (0.60-1.07) and 0.81 (0.60-1.10) for participants in the second and third tertiles, respectively, compared with those in the lowest (p-trend = 0.17). However, a statistically significant inverse association was observed between circulating 1,25(OH)2D concentration and odds of proximal metachronous adenoma, with an OR (95 % CI) of 0.71 (0.52-0.98) for individuals in the highest tertile of 1,25(OH)2D compared with those in the lowest (p-trend = 0.04). While there was no relationship overall between 1,25(OH)2D and metachronous distal lesions, there was a significantly reduced odds for women, but not men, in the highest 1,25(OH)2D tertile compared with the lowest (OR 0.53; 95 % CI 0.27-1.03; p-trend = 0.05; p-interaction = 0.08). The observed differences in associations with proximal and distal adenomas could indicate that delivery and activity of vitamin D metabolites in different anatomic sites in the colorectum varies, particularly by gender. These results identify novel associations between 1,25(OH) 2D and metachronous proximal and distal colorectal adenoma, and suggest that future studies are needed to ascertain potential mechanistic differences in 1,25(OH)2D action in the colorectum.

AB - Cellular-level studies demonstrate that the availability of the secosteroid hormone 1α,25-dihydroxyvitamin D [1,25(OH)2D] to colon cells promotes anti-carcinogenic activities. Although epidemiological data are relatively sparse, suggestive inverse trends have been reported between circulating 1,25(OH)2D concentration and colorectal neoplasia. We therefore sought to evaluate the relationship between circulating 1,25(OH) 2D concentrations and odds for metachronous colorectal adenomas among 1,151 participants from a randomized trial of ursodeoxycholic acid for colorectal adenoma prevention. No relationship between 1,25(OH)2D and overall odds for metachronous lesions was observed, with ORs (95 % CIs) of 0.80 (0.60-1.07) and 0.81 (0.60-1.10) for participants in the second and third tertiles, respectively, compared with those in the lowest (p-trend = 0.17). However, a statistically significant inverse association was observed between circulating 1,25(OH)2D concentration and odds of proximal metachronous adenoma, with an OR (95 % CI) of 0.71 (0.52-0.98) for individuals in the highest tertile of 1,25(OH)2D compared with those in the lowest (p-trend = 0.04). While there was no relationship overall between 1,25(OH)2D and metachronous distal lesions, there was a significantly reduced odds for women, but not men, in the highest 1,25(OH)2D tertile compared with the lowest (OR 0.53; 95 % CI 0.27-1.03; p-trend = 0.05; p-interaction = 0.08). The observed differences in associations with proximal and distal adenomas could indicate that delivery and activity of vitamin D metabolites in different anatomic sites in the colorectum varies, particularly by gender. These results identify novel associations between 1,25(OH) 2D and metachronous proximal and distal colorectal adenoma, and suggest that future studies are needed to ascertain potential mechanistic differences in 1,25(OH)2D action in the colorectum.

KW - Colon cancer

KW - Colorectal adenoma

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=84904558231&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904558231&partnerID=8YFLogxK

U2 - 10.1007/s10552-014-0382-6

DO - 10.1007/s10552-014-0382-6

M3 - Article

C2 - 24737199

AN - SCOPUS:84904558231

VL - 25

SP - 809

EP - 817

JO - Cancer Causes and Control

JF - Cancer Causes and Control

SN - 0957-5243

IS - 7

ER -